Cargando…

The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia

Febrile neutropenia (FN) represents one of the main complications of pediatric patients with oncological and hematological diseases. In these patients, it is crucial to identify bacterial infections. The aim of this study is to evaluate presepsin as an early biomarker of bacterial infections during...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cerasi, Sara, Leardini, Davide, Lisanti, Nunzia, Belotti, Tamara, Pierantoni, Luca, Zama, Daniele, Lanari, Marcello, Prete, Arcangelo, Masetti, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119114/ https://www.ncbi.nlm.nih.gov/pubmed/37081067 http://dx.doi.org/10.1038/s41598-023-33094-2

Ejemplares similares

Author Correction: The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia
por: Cerasi, Sara, et al.
Publicado: (2023)

Febrile Neutropenia Duration Is Associated with the Severity of Gut Microbiota Dysbiosis in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Masetti, Riccardo, et al.
Publicado: (2022)

Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients
por: Koizumi, Yusuke, et al.
Publicado: (2017)

The emerging role of nutritional support in the supportive care of pediatric patients undergoing hematopoietic stem cell transplantation
por: Muratore, Edoardo, et al.
Publicado: (2023)

Antimicrobial Stewardship Interventions in Pediatric Oncology: A Systematic Review
por: Muratore, Edoardo, et al.
Publicado: (2022)

The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients
por: Moustafa, Rania, et al.
Publicado: (2021)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia
por: Stoma, Igor, et al.
Publicado: (2019)

Pharmacomicrobiomics in Pediatric Oncology: The Complex Interplay between Commonly Used Drugs and Gut Microbiome
por: Leardini, Davide, et al.
Publicado: (2022)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

Diagnostic Radiology in Hematological Patients with Febrile Neutropenia
por: Heussel, Claus Peter
Publicado: (2014)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
por: Cennamo, Federica, et al.
Publicado: (2021)

Survey of practices for the clinical management of febrile neutropenia in children in hematology-oncology units in Latin America
por: Melgar, Mario A., et al.
Publicado: (2021)

Activity of a Pediatric Emergency Department of a Tertiary Center in Bologna, Italy, during SARS-CoV-2 Pandemic
por: Zama, Daniele, et al.
Publicado: (2022)

The Role of Nutrition in Primary and Secondary Prevention of Cardiovascular Damage in Childhood Cancer Survivors
por: Guida, Fiorentina, et al.
Publicado: (2022)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
por: Demirel, Aslıhan, et al.
Publicado: (2015)

Oral Lactoferrin Supplementation during Induction Chemotherapy Promotes Gut Microbiome Eubiosis in Pediatric Patients with Hematologic Malignancies
por: D’Amico, Federica, et al.
Publicado: (2022)

Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics
por: Scarpini, Sara, et al.
Publicado: (2022)

Effectiveness of Quinolone Prophylaxis in Pediatric Acute Leukemia and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis
por: Leardini, Davide, et al.
Publicado: (2022)

Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia
por: Teofili, Luciana, et al.
Publicado: (2016)

Predictors of Septic Shock or Bacteremia in Children Experiencing Febrile Neutropenia Post-Chemotherapy
por: Avilés-Robles, Martha, et al.
Publicado: (2022)

A questionnaire survey on evaluation for penetration and compliance of the Japanese Guideline on Febrile Neutropenia among hematology-oncology physicians and surgeons
por: Akiyama, Nobu, et al.
Publicado: (2021)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2014)

Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics
por: Lappalainen, Marika, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
por: Álvarez, José C., et al.
Publicado: (2021)

The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia
por: Jungrungrueng, Thanyathorn, et al.
Publicado: (2021)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients
por: Lakshmaiah, Kuntegowdanahalli C, et al.
Publicado: (2015)

Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
por: Álvarez, José C, et al.
Publicado: (2013)

Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2019)

Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia
por: Korpelainen, Sini, et al.
Publicado: (2017)

Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study
por: Kroloff, Maxwell, et al.
Publicado: (2022)

Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation
por: Zama, Daniele, et al.
Publicado: (2020)

Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
por: Hodgson-Viden, Heather, et al.
Publicado: (2005)

Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia
por: Thangthong, Jutarat, et al.
Publicado: (2020)

Diagnosis and Management of Febrile Neutropenia in Pediatric Oncology Patients—A Systematic Review
por: Boeriu, Estera, et al.
Publicado: (2022)

All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia
por: Shmuely, Haim, et al.
Publicado: (2023)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oe1v6jofuo4fg521p1ho3nuu1i